Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial (Q36219254)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial |
scientific article |
Statements
1 reference
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial (English)
1 reference
Eleftherios P Mamounas
1 reference
Harry D Bear
1 reference
Gong Tang
1 reference
Priya Rastogi
1 reference
Charles E Geyer
1 reference
Qing Liu
1 reference
André Robidoux
1 reference
Luis Baez-Diaz
1 reference
Adam M Brufsky
1 reference
Rita S Mehta
1 reference
Louis Fehrenbacher
1 reference
James A Young
1 reference
Francis M Senecal
1 reference
Rakesh Gaur
1 reference
Richard G Margolese
1 reference
Paul T Adams
1 reference
Howard M Gross
1 reference
Joseph P Costantino
1 reference
Norman Wolmark
1 reference
1 reference
Identifiers
1 reference